Table 45b:
Reference Case Analysis Results, Migraine
| Strategy | Average total cost, $ (95% CrI) | Incremental cost, $ (95% CrI)a,b | Average total effect, QALYs (95% CrI) | Incremental effect, QALYs (95% CrI)b,c | ICER, $/QALYc |
|---|---|---|---|---|---|
| Standard care alone | 2,877 (2,818 to 2,934) | - | 0.7809 (0.7533 to 0.8076) | - | - |
| nVNS in addition to standard care | 9,200 (8,892 to 9,507) | 6,324 (6,016 to 6,642) | 0.7876 (0.7595 to 0.8144) | 0.0066 (-0.0053 to 0.0186) | 952,116 |
Abbreviations: ICER, incremental cost-effectiveness ratio; nVNS; noninvasive vagus nerve stimulation; QALY, quality-adjusted life-year.
a
Incremental cost = average cost (nVNS with standard care) - average cost (standard care alone).
b
Results may appear inexact due to rounding.
c
Incremental effect = average effect (nVNS with standard care) - average effect (standard care alone).